NCT03831230Completed
Constitution of ex Vivo Ovarian Tumor Models for the Validation of the Interest of Innovative Therapies and the Search for Tumor or Circulating Biomarkers Predictive of Treatment Response
Source: ClinicalTrials.gov · Last updated 8 Aug 2025
Brief summary (registry, in English)
Development of ex vivo models of ovarian cancer, fallopian tubes or peritoneum.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 250 (actual)
- First submitted
- 28 Jan 2019
- Start date
- 7 Mar 2019
- Primary completion date
- 27 Feb 2025
- Lead sponsor
- Centre Francois Baclesse
- Diseases
- Ovarian cancer
- NCT number
- NCT03831230
What you commit to
- Study type: Observational
- Participants enrolled: 250
- From 7 Mar 2019 to the primary completion date, 27 Feb 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- History of any other clinically active malignancy in the last 5 years prior to inclusion
Other
- Pregnant woman
- Persons deprived of liberty or guardianship (including curatorship)
Who the study is looking for
- Patient over 18 years old.
- Patient with ovarian cancer, carcinoma of the fallopian tubes, or histologically proven peritoneum. All FIGO stages are accepted for the study.
- Patient to be managed by surgery (laparoscopy and / or laparotomy).
Age in the registry: 18 years to - · Sex: Female · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Centre François Baclesse Coordinator of this site? Confirm its status | Caen | France | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.